Back to search

Article

A Real-World Pharmacovigilance Study of Ceftazidime/avibactam: Data Mining of the FDA Adverse Event Reporting System (FAERS) Database

2024-01-10

Abstract excerpt

<title>Abstract</title> <p>Introduction Ceftazidime/avibactam (CAZ/AVI) is a combination of a well-known third-generation, broad-spectrum cephalosporin with a new beta-lactamase inhibitor that has been approved for the treatment of various infectious diseases (especially MDR-GNB infections) by the FDA. Aim The present study extensively assessed real-world CAZ/AVI-related adverse events (AEs) through data mining...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c4fae95e-622c-536a-8b04-4ec6372c17e8
DOI
10.21203/rs.3.rs-3802796/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Real-World Pharmacovigilance Study of Ceftazidime/avibactam: Data Mining of the FDA Adverse Event Reporting System (FAERS) DatabaseDOI 10.21203/rs.3.rs-3802796/v1
Select a neighboring publication to make it the new centre.